ReviewJournal of diabetes2022

Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes.

Inah Camaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.